| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.5M | +119.3% |
| SG&A Expense | $6.1M | +72.3% |
| Operating Income | -$16.6M | -99.4% |
| Income Tax | $0 | — |
| Net Income | -$16.3M | -54.4% |
| EPS (Basic) | -$1.17 | +15.2% |
| EPS (Diluted) | -$1.17 | +15.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -69.7% |
| Current Assets | $3.4M | -78.3% |
| Total Assets | $4.8M | -72.3% |
| Current Liabilities | $1.8M | -55.7% |
| Total Liabilities | $1.9M | -54.9% |
| Stockholders' Equity | $2.9M | -77.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | -111.2% |
| Investing Cash Flow | $6.4M | +205.5% |
| Financing Cash Flow | $2.9M | -85.8% |